Viewing Study NCT00152061


Ignite Creation Date: 2025-12-24 @ 12:55 PM
Ignite Modification Date: 2025-12-27 @ 9:59 PM
Study NCT ID: NCT00152061
Status: COMPLETED
Last Update Posted: 2013-06-19
First Post: 2005-09-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens
Sponsor: Stanford University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 74009
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View